Physicians networking MDVIP announced this week that Exact Sciences‘ Cologuard is now available by prescription in its system. “MDVIP’s adoption of Cologuard marks an important step for Exact Sciences in allowing a…
Healthcare technology company Isomark LLC announced Wednesday it received a $1.7 million Small Business Innovation Research grant from the National Institutes of Health. The grant will be used to fund its development and…
SHINE Medical Technologies announced last week it will receive up to $125 million of debt and equity financing in a term sheet executed with New York-based Deerfield Management Company. According to a…
Exact Sciences announced Thursday that Cologuard, the first FDA-approved non-invasive screening test for colorectal cancer and precancer, will be covered by The Centers for Medicare & Medicaid Services (CMS). “We are…
Exact Sciences‘ Cologuard, which received its FDA approval last month, will be offered to Group Health Cooperative patients, the organization announced recently. GHC will be the first health plan in Wisconsin to…
Echometrix, a Madison-based developer of proprietary musculoskeletal ultrasound technology, was awarded a patent on its ultrasound technology for the dynamic functional analysis of injured and healing tissues, the company announced…
PSC Biotech announced recently that it plans to house its newly launched subsidiary BioTechnique at University Research Park and be fully operational next year. According to a release, BioTechnique will…
Cellular Dynamics International has strengthened its grip on the stem cell market, as the company announced today that it received a U.S. patent on the automated production of human pluripotent…
A major milestone for Exact Sciences was achieved Monday, when the company announced its colorectal cancer screening test called Cologuard received approval from the U.S. Food and Drug Administration (FDA). “The FDA…
Cellectar Biosciences, which develops agents to detect, treat and monitor cancers, announced today it has applied to the U.S. Food & Drug Administration to begin a clinical study of a highly-selective,…
